Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
4.
Article in Romanian | MEDLINE | ID: mdl-6254127

ABSTRACT

The late results are analized, of a strictly supervised treatment of 160 patients with pulmonary tuberculosis, of the secondary bacilliferic type, recently discovered, between July 1974 and December 1976. The criterium for assessing the results was the bacteriologic examination. After the first year 144 of the patients became negative (90%), while 16 remained positive (10%). Prolonged treatment, up to 2--3 years also led to negativation of these causes, with the only exception of a single patient that did not cooperate, and who became chronically ill. After one-and-a-half year 2 patients again became positive, of which one died with fulminating hemophytysis, and the second one in cardio-respiratory failure. Another 6 patients became positive after two years, while two other were positive at three years and one each after four, respectively five years. Two are still under treatment, while the remaining patients were all negative for at least two years. At the end of the observation period 155 of the initially 160 bacilliferic patients were considered as solved, and do not raise anti-epidemic problems. It is shown in conclusion that the modern anti-tuberculous treatment can lead to recovery of the majority of patients. Those who are still bacille carriers, or who recidivate, can also be solved by continued treatment for a period of up to 2--3 years. The patients with multiple deficiencies have increased risks to develop relcidives, and they should be followed with perseverance for a long time. The recommended therapeutic regimens are not significantly different from the viewpoint of their efficiency, provided they are administered in a strictly supervised manner. The reactivity of the organism probably has an important role in the efficiency of the modern anti-tuberculous treatment.


Subject(s)
Antitubercular Agents/therapeutic use , Tuberculosis, Pulmonary/drug therapy , Adolescent , Adult , Aged , Ambulatory Care , Drug Resistance, Microbial , Female , Follow-Up Studies , Humans , Male , Microbial Sensitivity Tests , Middle Aged , Mycobacterium tuberculosis/drug effects , Mycobacterium tuberculosis/isolation & purification , Sputum/microbiology
6.
Article in Romanian | MEDLINE | ID: mdl-212815

ABSTRACT

The immediate and the late results are analyzed, of resumption of treatment with RMP and EMB in 50 patients with relapsing pulmonary tuberculosis that had not been treated with these drugs previously. After the first year of treatment negativation of the sputum by microscopy and culture was obtained in 45 of the patients, while 5 remained still positive. In the following two years 7 of the negative patients became positive again and finally 8 were solved completely and 4 became chronically ill. The most important of the unfavourable factors were simultaneous radiological and bacteriological relapses and chronic alcoholism. There was no primary or secondary resistance against the drugs used in the treatment. Intolerance to the drugs, although frequent, did not significantly affect the course of the treatment, especially because it occurred only at a later time.


Subject(s)
Ethambutol/therapeutic use , Rifampin/therapeutic use , Tuberculosis, Pulmonary/drug therapy , Adolescent , Adult , Aged , Ethambutol/administration & dosage , Female , Humans , Male , Middle Aged , Recurrence , Rifampin/administration & dosage , Time Factors
8.
Article in Romanian | MEDLINE | ID: mdl-171728

ABSTRACT

A correlation was made of routine spyrographic data with the scintigraphic aspects of the lungs in 146, respectively 100 patients with bronchopulmonary diseases. The following conclusions can be inferred: 1) normal spirographic values do not necessarily reflect an integrity of the respiratory function. Besides these values pulmonary perfusion can be severily altered; 2) the more deteriorated the spirographic values the more probable will be the alteration of the pulmonary perfusion; 3) in the evaluation of the respiratory function one cannot base on the routine spirographic data if these are within normal limits, especially before pulmonary surgery is performed, or before the patients are resuming active life; according to possibilities, the scintigraphic investigation is to be performed.


Subject(s)
Bronchial Diseases/physiopathology , Lung Diseases/physiopathology , Radionuclide Imaging , Respiration , Humans , Spirometry
SELECTION OF CITATIONS
SEARCH DETAIL